This inventor holds 1 USPTO granted patent. Top assignee: Atai Therapeutics Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovations of Benjamin Robert Difrancesco
Introduction
Benjamin Robert Difrancesco is an accomplished inventor based in Encinitas, California. He has made significant contributions to the field of pharmaceuticals, particularly in the area of mental health treatment. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Benjamin holds a patent for "Dimethoxyphenylalkylamine activators of serotonin receptors." This patent includes compounds of Formula (I) or pharmaceutically acceptable salts thereof. The patent outlines pharmaceutical compositions that incorporate these compounds and methods for their use in treating mental health diseases or disorders. He has 1 patent to his name, showcasing his dedication to advancing medical science.
Career Highlights
Benjamin is currently associated with Atai Therapeutics Inc., a company focused on developing innovative treatments for mental health conditions. His work at Atai Therapeutics has positioned him as a key player in the pharmaceutical industry, contributing to groundbreaking research and development.
Collaborations
Throughout his career, Benjamin has collaborated with notable professionals in the field, including Glenn Short and Robert B Perni. These collaborations have enhanced his research and expanded the impact of his innovations.
Conclusion
Benjamin Robert Difrancesco exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in mental health treatment, highlight the importance of research and development in improving lives. His work continues to inspire future advancements in the field.